155 related articles for article (PubMed ID: 18985626)
1. Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat.
Perrine SA; Michaels MS; Ghoddoussi F; Hyde EM; Tancer ME; Galloway MP
NMR Biomed; 2009 May; 22(4):419-25. PubMed ID: 18985626
[TBL] [Abstract][Full Text] [Related]
2. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats.
Gramsbergen JB; Cumming P
Neurochem Int; 2007 Jul; 51(1):8-15. PubMed ID: 17475367
[TBL] [Abstract][Full Text] [Related]
3. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
4. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
Stanley N; Salem A; Irvine RJ
Neuroscience; 2007 Apr; 146(1):321-9. PubMed ID: 17306465
[TBL] [Abstract][Full Text] [Related]
5. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
6. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
Freezer A; Salem A; Irvine RJ
Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
[TBL] [Abstract][Full Text] [Related]
7. MDMA (ecstasy) effects in pubescent rats: Males are more sensitive than females.
Koenig J; Lazarus C; Jeltsch H; Ben Hamida S; Riegert C; Kelche C; Jones BC; Cassel JC
Pharmacol Biochem Behav; 2005 Jul; 81(3):635-44. PubMed ID: 15951008
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
Hewton R; Salem A; Irvine RJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic neurotoxic metabolites of ecstasy identified in rat brain.
Jones DC; Duvauchelle C; Ikegami A; Olsen CM; Lau SS; de la Torre R; Monks TJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):422-31. PubMed ID: 15634943
[TBL] [Abstract][Full Text] [Related]
10. Human Metabolome Changes after a Single Dose of 3,4-Methylenedioxymethamphetamine (MDMA) with Special Focus on Steroid Metabolism and Inflammation Processes.
Boxler MI; Streun GL; Liechti ME; Schmid Y; Kraemer T; Steuer AE
J Proteome Res; 2018 Aug; 17(8):2900-2907. PubMed ID: 29947220
[TBL] [Abstract][Full Text] [Related]
11. Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.
Jaehne EJ; Majumder I; Salem A; Irvine RJ
Addict Biol; 2011 Jan; 16(1):7-19. PubMed ID: 20192951
[TBL] [Abstract][Full Text] [Related]
12. MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain.
Perrine SA; Ghoddoussi F; Michaels MS; Hyde EM; Kuhn DM; Galloway MP
Neurotoxicology; 2010 Dec; 31(6):654-61. PubMed ID: 20800616
[TBL] [Abstract][Full Text] [Related]
13. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
Jones K; Brennan KA; Colussi-Mas J; Schenk S
Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
[TBL] [Abstract][Full Text] [Related]
14. MDMA induces EPSP-Spike potentiation in rat ventral hippocampus in vitro via serotonin and noradrenaline release and coactivation of 5-HT4 and beta1 receptors.
Mlinar B; Mascalchi S; Morini R; Giachi F; Corradetti R
Neuropsychopharmacology; 2008 May; 33(6):1464-75. PubMed ID: 17653110
[TBL] [Abstract][Full Text] [Related]
15. Potential long-term effects of MDMA on the basal ganglia-thalamocortical circuit: a proton MR spectroscopy and diffusion-tensor imaging study.
Liu HS; Chou MC; Chung HW; Cho NY; Chiang SW; Wang CY; Kao HW; Huang GS; Chen CY
Radiology; 2011 Aug; 260(2):531-40. PubMed ID: 21633053
[TBL] [Abstract][Full Text] [Related]
16. Roles of 3,4-methylenedioxymethamphetamine (MDMA)-induced alteration of connexin43 and intracellular Ca(2+) oscillation in its cardiotoxicity.
Zhuo L; Liu Q; Liu L; Sun TY; Wang RS; Qu GQ; Liu Q; Liu Y; Ren L
Toxicology; 2013 Aug; 310():61-72. PubMed ID: 23747752
[TBL] [Abstract][Full Text] [Related]
17. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
[TBL] [Abstract][Full Text] [Related]
18. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
[TBL] [Abstract][Full Text] [Related]
19. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
